Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.95 GBX | -0.83% | +6.68% | -31.96% |
05-01 | Norcros sets out strategic aims; Synthomer seals sale | AN |
04-16 | System1 revenue jumps; Pathfinder amends deal | AN |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company is one of the best yield companies with high dividend expectations.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Most analysts recommend that the stock should be sold or reduced.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-31.96% | 155M | C | ||
-3.76% | 47.59B | A- | ||
-4.96% | 21.08B | A- | ||
-1.33% | 13.48B | A- | ||
+19.34% | 11.96B | A | ||
-6.31% | 9.63B | B+ | ||
-1.01% | 8.46B | A- | ||
-16.17% | 8.27B | B- | ||
+3.00% | 7.82B | A- | ||
-17.86% | 5.62B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RGL Stock
- Ratings Regional REIT Limited